Editorial Article Open Access Cerebral Bioenergetics & Neuro-Metabolic Rescue

Quantum Theories of Consciousness in Psychiatry: The Orchestrated Objective Reduction (Orch-OR) Hypothesis

Published: 11 May 2026 · Olympia R&D Bulletin · Permalink: olympiabiosciences.com/rd-hub/quantum-consciousness-psychiatry-orch-or/ · 37 sources cited · ≈ 13 min read
Quantum Theories of Consciousness in Psychiatry: The Orchestrated Objective Reduction (Orch-OR) Hypothesis — Cerebral Bioenergetics & Neuro-Metabolic Rescue scientific visualization

Industry Challenge

Developing therapeutic interventions that modulate consciousness or psychiatric pathology requires targeting quantum-level phenomena within neuronal microtubules, posing a significant challenge for conventional drug design and delivery given the elusive nature of these mechanisms.

Olympia AI-Verified Solution

Olympia Biosciences™ leverages advanced AI-driven computational neuroscience and quantum biology modeling to identify and validate novel microphysical targets, enabling the development of precision interventions for consciousness-related disorders and psychiatric conditions.

💬 Not a scientist? 💬 Get a plain-English summary

In Plain English

Scientists are exploring why our traditional understanding of the brain doesn't fully explain how we have thoughts, feelings, and awareness. One exciting idea suggests that the mysterious world of quantum physics, which governs tiny particles, might play a role in consciousness. Specifically, one prominent theory proposes that consciousness arises from incredibly small calculations happening within tiny structures, like internal scaffolds, inside our brain cells, rather than just from how these cells connect. This concept could help us understand how things like anesthesia work and might even offer new insights into certain mental health conditions.

Olympia already has a formulation or technology that directly addresses this research area.

Talk to us →

Summary

A recurrent motivation for importing quantum theory into psychiatry and related clinical neuroscience is the claim that standard computational/neurobiological descriptions leave core features of subjectivity insufficiently explained, including that “the mechanism by which the brain generates thoughts and feelings remains unknown” and that “calculation alone cannot explain why we have feelings, awareness and ‘inner life’.”[1] In this context, several authors argue that “features of consciousness difficult to understand in terms of conventional neuroscience have evoked application of quantum theory,” positioning quantum models as attempts to account for consciousness, agency, and related clinical phenomena such as anesthesia-induced loss of consciousness.[2, 3]

Across the literature represented here, “quantum” enters psychiatry in (at least) two distinct ways: (i) mechanistic hypotheses proposing biologically instantiated non-classical states (e.g., microtubule coherence and objective-collapse models), and (ii) formal mathematical frameworks (quantum probability / Hilbert-space models) used to represent contextual, ambiguous, or non-classical patterns in cognition and psychopathology.[4] Some sources explicitly advocate this move on translational grounds, arguing for a “possible way to integrate experimental neuroscience with quantum models in order to address outstanding issues in psychopathology,” and also proposing a “grounding of psychiatric disease” in quantum microphysical phenomena.[1, 5]

Orch-OR

Orchestrated Objective Reduction (Orch-OR) is the most developed and most frequently cited quantum-consciousness theory in this dataset, and it is repeatedly presented as directly relevant to clinically controllable consciousness phenomena (especially general anesthesia) and, more speculatively, to psychiatric illness via microtubule/cytoskeletal abnormalities and consciousness-related symptom domains.[6–8]

Core proposal

The core Orch-OR claim is that “consciousness” is attributable to “quantum computations in microtubules inside brain neurons,” rather than arising solely from synaptic/network-level information processing.[6, 7] Within this framing, microtubule states are treated as qubit-like superpositions that can “unify by entanglement… until reduction, or ‘collapse’ to definite output states,” and the Orch-OR account emphasizes that microtubule oscillations “entangle, compute, and terminate (‘collapse of the wavefunction’) by Penrose objective reduction (‘OR’).”[6, 7]

A distinctive feature is Penrose’s objective-collapse stance: “Rather than consciousness causing collapse/reduction, Penrose proposed that collapse/reduction occurred spontaneously,” with collapse linked to a property of the universe connected to (‘proto-’)consciousness.[9] Related formulations describe OR as a “new physics of objective reduction… [appealing] to a form of quantum gravity,” and define conscious moments as occurring when coherent superposition persists until an “objective… threshold related to quantum gravity” is met, at which point the system “self-reduces (objective reduction: OR).”[10]

In several Orch-OR texts, these reduction events are explicitly discretized and connected to psychophysical timing: quantum computations are described as “discrete events of roughly 25 msec duration (coupled to gamma synchrony EEG)… culminating in a conscious moment (e.g., at 40 Hz).”[3] A closely aligned statement describes Orch-OR as identifying “discrete conscious moments” with microtubule quantum computations “40/s in concert with gamma synchrony EEG.”[11]

Orchestration and MAPs

Orch-OR’s “orchestration” is commonly attributed to biological control over quantum dynamics, especially via microtubule-associated proteins (MAPs).[12] Multiple sources propose that MAP attachments “tune” microtubule quantum oscillations and “orchestrate” possible collapse outcomes, thereby shaping which classical “outcome states” of tubulin are realized and how they implement neurophysiological functions after reduction.[12, 13]

Evidence and predictions

A central empirical motivation in the Orch-OR literature is anesthesia, with claims that anesthetics “selectively erase consciousness by quantum interactions inside microtubules,” linking a controllable clinical phenomenon to a specific microtubule-scale mechanism.[6] Related formulations propose a testable prediction: “A correlation between anesthetic dampening of quantum beats in microtubules, and anesthetic clinical potency would validate ‘Orch’ as a (sub-)neural correlate of consciousness.”[6] One prominent Orch-OR paper explicitly treats this prediction as potentially falsifying: “If quantum interference in tubulin/microtubules is not found, or if found is not dampened by anesthetics, then Orch (and Orch OR) would be falsified.”[7]

Several sources also point to room-temperature microtubule quantum effects as relevant empirical background, asserting that “experiments have now demonstrated nontrivial quantum effects in MTs at room temperature.”[14] More recent work is described as suggestive of quantum-optical transport beyond classical expectations, reporting that “ultraviolet-induced exciton propagation through microtubules exceeded classical expectations… suggesting a quantum optical effect.”[15]

On the neurophysiological side, Orch-OR is often discussed alongside gamma-band synchrony and the anesthetic loss of gamma coherence: loss of consciousness during general anesthesia is described as a “disappearance of frontal-posterior gamma EEG coherence” that returns on awakening.[3] Another proposed bridge from microtubule-scale dynamics to EEG is the “beat frequencies” hypothesis, introduced as “a possible source of the observed… EEG correlates of consciousness.”[16]

A further empirical-leaning extension uses transcranial ultrasound (TUS) as a possible modulator of microtubule-scale dynamics, reporting a pilot finding that applying “8 megahertz… to the temple… found improved mood for 40 minutes after ultrasound.”[17] The same account suggests follow-up work and proposes clinical targets for TUS trials, explicitly naming “PTSD” and “depression” among suggested applications.[17]

Finally, one Orch-OR-associated account explicitly extends microtubule “quantum channels” to psychoactive drugs, claiming that “psychedelic drugs… can bind in quantum channels in tubulin” and may “increase frequency of microtubule quantum dipole resonances and Orch OR events,” thereby “expanding” consciousness.”[17]

Critiques and constraints

Critiques focus on both physical plausibility and biological scaling, with decoherence concerns frequently noted in the Orch-OR-adjacent literature (e.g., that “decoherence… would destroy quantum states before they could have an impact on brain activity”).[18] A broader critical review of quantum approaches to consciousness emphasizes an evidential gap at the mechanistic level, stating that “no study to date has demonstrated entanglement, long-lived coherence, or collapse dynamics in neural tissue under operational criteria comparable to those used in controlled quantum systems.”[4]

A specific quantitative criticism targets Orch-OR’s biological parameterization, arguing that a commonly repeated tubulin-count estimate is incorrectly sourced: “nowhere in [Yu and Baas (1994)] is estimated that there are tubulin dimers per neuron,” and a reconstruction implying “tubulin dimers” per neuron is used to argue that (under particular assumptions) “only 15 neurons participate in each conscious event,” challenging Orch-OR’s scaling claims.[19]

Other critiques emphasize the theory’s incomplete status and multiplicity of collapse-model implementations, noting that “Orch OR is not a complete model of reality but a work in progress,” and that “there are many ways one could make these base ideas precise hence many ‘variants’,” so that experimental exclusions may “cut out a small class of possible variants” rather than refuting the entire program.”[20]

Quantum brain dynamics

A second major tradition is quantum brain dynamics (QBD) and related quantum-field-theoretic approaches, which aim to describe brain function “within the realm of quantum field theory” and to treat advanced functions like consciousness and memory as emergent from macroscopic order parameters and field dynamics rather than from neuron-network computation alone.[21, 22]

One representative description presents “a new quantum framework for investigating advanced functions of the brain such as consciousness and memory,” explicitly grounding it in “the quantum field theory originated… by… Hiroomi Umezawa.”[22] In this depiction, “memory” is described as stored in “a state of macroscopic order,” and “consciousness” is described as realized by “creation and annihilation dynamics of energy quanta of the electromagnetic field and molecular fields of water and protein.”[22]

A related QBD-adjacent line of work proposes specific quantum-optical mechanisms in microtubules, including collective emission (“superradiance”) and nonlinear propagation (“self-induced transparency”).[23] In that framework, “superradiant optical computing in networks of microtubules… may provide a basis for biomolecular cognition and a substrate for consciousness,” and “general anesthesia may be explained by blockade of quantum level events” supporting collective cooperative macro-level dynamics.[23] A closely aligned statement similarly proposes that “anesthetic gas molecules reversibly inhibit consciousness by weak… binding in hydrophobic regions of proteins,” and infers that if microtubule “quantum optical coherence… is essential for consciousness,” anesthetics “must somehow inhibit it.”[24]

Quantum cognition

Quantum cognition (QC) uses quantum-theoretic mathematics as a formal language for cognition, proposing that mental dynamics can be represented by context-sensitive “states” and non-classical probability structure, rather than assuming stable classical propositions and Kolmogorovian probability in every cognitive domain.[25]

One clinically oriented QC review states that QC “proposes an alternative theoretical framework to classical logic” for phenomena such as “ambivalence, overlapping intentions, and sudden changes in perspective,” and argues that quantum-theory equations “allow us to formally represent mental dynamics characterized by ambivalence, decision fluctuations, sensitivity to context, and unconscious behaviors.”[25] It explicitly suggests clinical relevance by claiming these characteristics are “very evident” in “personality disorders… characterized by emotional instability,” and gives a concrete example: “a borderline patient may simultaneously desire and fear the closeness of a significant figure.”[25]

A broader critical review of quantum approaches to consciousness formalizes the key distinction between QC-like formalisms and mechanistic quantum-brain proposals, stating that quantum principles may offer leverage “as formal mathematical frameworks for modeling contextual cognition” or “as mechanistic hypotheses proposing biologically instantiated non-classical states.”[4] It also frames the evidential standard for mechanistic claims, emphasizing that “the decisive question is not whether the brain is quantum, but whether its dynamics exceed the explanatory reach of rigorously defined classical models.”[4]

Clinical connections

The literature represented here links quantum models to psychiatry along several clinically salient axes, including psychosis and self-disturbance, mood disorders, anesthesia and controllable changes of consciousness, and time/agency-related anomalies that some authors interpret as relevant to psychopathology and volition.[3, 5, 11, 26]

Schizophrenia

A schizophrenia-focused review explicitly proposes Orch-OR as “an attractive proposition to understand the biology of consciousness,” stating that it “invokes quantum processes in the microtubules of neurons,” and arguing that the model is “particularly important for understanding schizophrenia… due to the shared ‘scaffold’ of microtubules.”[26] The same review frames schizophrenia as a consciousness disorder, citing evidence for “self-abnormalities, aberrant time perception as well as dysfunctional intentional binding,” and linking these to “aberant neural oscillations as well as micro-tubule abnormalities,” culminating in the postulate that “Schizophrenia is a disorder of consciousness possibly due to microtubule dysfunction.”[26]

Other schizophrenia-adjacent approaches are more formal or metaphorical rather than microphysical, such as a proposal of “a quantum logic… of the psychodynamic unconscious,” with the claim that this “sub rosa quantum logic… is also the dominant… logic of schizophrenia,” and the suggestion that psychotherapists might learn a “formal Quantum Meta-language” to communicate more effectively with patients.[27]

More broadly, a quantum-paradigms paper suggests candidate mappings from quantum-state descriptors to psychotic phenomenology, proposing that “shifts from coherent to incoherent quantum brain states may, when aberrant, flag neural correlates of psychotic perception,” and that “mismatched phase relations” may “shed light on clinical thought disorders.”[28] A psychiatry-oriented opinion piece likewise claims that “Quantum approaches could presumably help us to understand much about hallucinations, delusions and other psychic abnormalities.”[29]

Depression and mood disorders

Depression is addressed in a proposal explicitly aiming to connect quantum models to psychopathology, arguing that quantum theories “offer a profound change to the current approaches,” and proposing integration with experimental neuroscience via the “stream of consciousness” and EEG “Gamma Synchrony (GS).”[5] Within that framework, “a unipolar depressed patient could be seen as a subject with an altered stream of consciousness,” with “clues” suggesting depression relates to an “increased power” stream of consciousness, and with an associated empirical claim that “Gamma synchrony… is somehow increased… in the temporal region.”[5]

Quantum neurobiology reviews also propose (still speculative) pathways linking quantum degrees of freedom to psychiatric treatment response, such as the suggestion that lithium efficacy “could be due to the increased decoherence induced by the lithium nuclear spins included in the Posner molecule.”[30] In parallel, the Orch-OR-adjacent ultrasound report describes an acute “improved mood” effect following brief TUS stimulation and suggests future trials targeting conditions including “PTSD” and “depression.”[17]

Anesthesia and altered consciousness

Anesthesia is a key test-bed across multiple quantum-mind traditions because it offers an experimentally and clinically controllable manipulation of consciousness.[3, 14] Orch-OR-oriented formulations argue for a “quantum hypothesis” in which anesthetics cause unconsciousness by “disrupting a delicate entangled collective quantum state of many neural MTs that constitutes the direct substrate of consciousness,” and further claim that the susceptibility of this coherent state to weak binding could explain why anesthetics appear selectively specific to consciousness at moderate doses.[14]

Other microtubule/quantum approaches claim that “microtubule ‘quantum channels’ in which anesthetics erase consciousness are identified,” and also propose microtubule-vibration “beat frequencies” as candidate mediators of EEG correlates of consciousness under anesthesia and waking.[16] In QBD/quantum-optics models, anesthesia is similarly framed as a blockade of quantum-level cooperative events, with explicit claims that “general anesthesia may be explained by blockade of quantum level events,” and that anesthetic gases inhibit consciousness through weak binding in hydrophobic protein regions that could disrupt essential coherence.[24]

Agency and time

Several Orch-OR sources connect quantum reduction to agency and volition, proposing that “each reduction/conscious moment selects particular microtubule states which regulate neuronal firings,” and that this can support “conscious causal agency.”[31] A related claim is that quantum state reductions entail “temporal non-locality,” potentially referring information “both forward and backward” in perceived time and thereby “rescu[ing] free will.”[31]

A time-focused Orch-OR treatment claims that “consciousness is due to quantum state (objective) reductions which create the flow of time,” and it explicitly states that “backward time effects… could enable real-time conscious control, and rescue conscious free will.”[9] Another statement similarly asserts that Orch-OR “can cause temporal non-locality, sending quantum information backward in classical time,” linking this to evidence claims in psychology and neuroscience and positioning it as a solution to a “too late” consciousness/agency timing problem.”[11] A further time-oriented summary asserts there are “credible reports of seemingly backward time effects in mental states,” and it attributes a possible mechanism to Penrose’s proposal that OR has a “retroactive effect” that deletes unselected spacetime curvatures, thereby enabling retroactive effects in “mental perceptions and actions.”[32]

Psychedelic states

Within an Orch-OR narrative that treats intracellular microtubule channels as relevant to consciousness modulation, one account claims that psychedelic drugs can enter cells and “bind in quantum channels in tubulin,” thereby increasing microtubule resonance frequency and Orch-OR events and “expanding” consciousness.”[17]

Shared concepts

Even where quantum physics is not taken literally as a brain mechanism, multiple strands share a small set of recurrent conceptual moves that can be mapped to psychiatric phenomena, notably superposition-like coexistence of incompatible tendencies, state-update or “collapse” as a decision/commitment event, entanglement-like holism as a model for unity/binding, and criticality/phase transitions as a model for abrupt shifts in conscious state.[14, 18, 25]

First, QC models treat ambivalence and overlapping intentions as central targets, explicitly using quantum formalisms to represent “ambivalence, overlapping intentions, and sudden changes in perspective,” with clinical exemplars such as borderline patients who “simultaneously desire and fear” closeness.[25] Second, Orch-OR formulations repeatedly center “collapse” as a generative event for conscious moments, describing consciousness as sequences of objective reductions (“self-collapses”) orchestrated in microtubules, and thereby treating discrete reductions as the mechanistic analog of stepwise moments of experience.[32]

Third, entanglement is invoked in mechanistic and quasi-mechanistic ways to account for unity and binding: one quantum consciousness account argues that large-scale consciousness requires “a single collective entangled quantum state,” and it suggests that unity of experience is tied to “the objective efficacious unity of the quantum physical substrate.”[14] Fourth, several Orch-OR-adjacent proposals recruit criticality language, describing self-organized criticality as a scale-invariant, power-law regime and treating collapse-like events as avalanche/transition phenomena occurring on psychophysical timescales (e.g., “10–200 ms” in some models).[18, 33]

Critical assessment

Across these literatures, a repeated methodological fault line concerns whether quantum ideas are used as (a) formal models of cognition and context effects or (b) literal claims about biologically instantiated non-classical states that must satisfy operational criteria comparable to laboratory quantum systems.[4] The strongest general caution represented here is that, although some findings have been interpreted as non-classical, “no study to date has demonstrated entanglement, long-lived coherence, or collapse dynamics in neural tissue” under operational criteria comparable to controlled quantum systems, and thus evaluation should focus on whether proposed models exceed well-defined classical alternatives.[4]

For Orch-OR specifically, a major open empirical dependency is the model’s reliance on microtubule quantum oscillations “entangled among neurons across the brain,” described as “a feature which has yet to be proven.”[34] The program does, however, present explicit falsifiability conditions tied to anesthesia, stating that failure to observe microtubule quantum interference (or its dampening by anesthetics) would falsify Orch-OR.[7]

In addition, some critiques are internal/quantitative, challenging the adequacy of the biological numbers used to support Orch-OR timescale and scale estimates, including claims of mis-citation in tubulin-count estimates and downstream implications for how many neurons could participate in a coherent Orch-OR event under given assumptions.[19] A separate critical synthesis (focused on feasibility) concludes that Orch-OR “lacks convincing experimental evidence, especially regarding the link between quantum computation in microtubules and neuronal activity.”[35]

Finally, even sympathetic discussions emphasize the need for theoretical refinement and variant-specific testing, stressing that Orch-OR “is… a work in progress” with many possible “variants,” and that excluding one concrete collapse-model implementation may only remove a “small class” of variants rather than addressing the entire conceptual proposal.[20]

Future directions

Several sources converge on the need for multiscale, testable models that explicitly connect microphysical hypotheses to measurable neurophysiology and clinical phenomena such as anesthesia and psychopathology-relevant symptoms.[5, 34] Recent Orch-OR developments explicitly aim at this by outlining “a quantum-classical framework” intended to support “integration into a testable and predictive multiscale model,” and by proposing that quantum-classical theory can generate “correlation functions, spectra, and thermodynamic properties” comparable to experiments.[34, 36]

In the broader quantum-neurobiology literature, one direction is to treat the brain as a highly non-linear system in which microlevel quantum events might be amplified upward, emphasizing that “minuscule fluctuations… need not be true” to cancel out in “highly non-linear systems like our brain,” and that “future experiments” may “find or disprove a link between ion channel coherence, field potentials and… quantum-like decision behavior.”[37] Another programmatic stance is that progress in “quantum neurobiology” depends on progress in quantum biology generally, and that many proposed neural quantum mechanisms remain “largely theoretical,” suggesting a staged approach in which biophysical sites and operational signatures are progressively narrowed and experimentally constrained.[30]

Clinically, several authors explicitly propose that microtubule and cytoskeletal models could motivate interventions aimed at “microtubule and cytoskeletal origins of neuropathology,” including depression, and they point to modalities such as ultrasound stimulation as plausible translational test cases because they are experimentally tractable and directly relevant to symptoms and states central to psychiatry.[8, 17]

Comparison

The table below summarizes how the main approaches differ in what “quantum” means and how each proposes relevance to psychiatry.

Author Contributions

O.B.: Conceptualization, Literature Review, Writing — Original Draft, Writing — Review & Editing. The author has read and approved the published version of the manuscript.

Conflict of Interest

The author declares no conflict of interest. Olympia Biosciences™ operates exclusively as a Contract Development and Manufacturing Organization (CDMO) and does not manufacture or market consumer end-products in the subject areas discussed herein.

Olimpia Baranowska

Olimpia Baranowska

CEO & Scientific Director · M.Sc. Eng. Applied Physics & Applied Mathematics (Abstract Quantum Physics & Organic Microelectronics) · Ph.D. Candidate in Medical Sciences (Phlebology)

Founder of Olympia Biosciences™ (IOC Ltd.) · ISO 27001 Lead Auditor · Specialising in pharmaceutical-grade CDMO formulation, liposomal & nanoparticle delivery systems, and clinical nutrition.

Proprietary IP

Interested in This Technology?

Interested in building a product around this science? We work with pharmaceutical companies, longevity clinics, and PE-backed brands to translate proprietary R&D into market-ready formulations.

Selected technologies may be offered exclusively to one strategic partner per category — initiate due diligence to confirm allocation status.

Discuss a Partnership →

References

37 sources cited

  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18.
  19. 19.
  20. 20.
  21. 21.
  22. 22.
  23. 23.
  24. 24.
  25. 25.
  26. 26.
  27. 27.
  28. 28.
  29. 29.
  30. 30.
  31. 31.
  32. 32.
  33. 33.
  34. 34.
  35. 35.
  36. 36.
  37. 37.

Global Scientific & Legal Disclaimer

  1. 1. B2B & Educational Purposes Only. The scientific literature, research insights, and educational materials published on the Olympia Biosciences website are provided strictly for informational, academic, and Business-to-Business (B2B) industry reference. They are intended solely for medical professionals, pharmacologists, biotechnologists, and brand developers operating in a professional B2B capacity.

  2. 2. No Product-Specific Claims.. Olympia Biosciences™ operates exclusively as a B2B contract manufacturer. The research, ingredient profiles, and physiological mechanisms discussed herein are general academic overviews. They do not refer to, endorse, or constitute authorized marketing health claims for any specific commercial dietary supplement, medical food, or end-product manufactured in our facilities. Nothing on this page constitutes a health claim within the meaning of Regulation (EC) No 1924/2006 of the European Parliament and of the Council.

  3. 3. Not Medical Advice.. The content provided does not constitute medical advice, diagnosis, treatment, or clinical recommendations. It is not intended to replace consultation with a qualified healthcare provider. All published scientific material represents general academic overviews based on peer-reviewed research and should be interpreted exclusively in a B2B formulation and R&D context.

  4. 4. Regulatory Status & Client Responsibility.. While we respect and operate within the guidelines of global health authorities (including EFSA, FDA, and EMA), the emerging scientific research discussed in our articles may not have been formally evaluated by these agencies. Final product regulatory compliance, label accuracy, and substantiation of B2C marketing claims in any jurisdiction remain the sole legal responsibility of the brand owner. Olympia Biosciences™ provides manufacturing, formulation, and analytical services only. These statements and raw data have not been evaluated by the Food and Drug Administration (FDA), the European Food Safety Authority (EFSA), or the Therapeutic Goods Administration (TGA). The raw active pharmaceutical ingredients (APIs) and formulations discussed are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this page constitutes a health claim within the meaning of EU Regulation (EC) No 1924/2006 or the U.S. Dietary Supplement Health and Education Act (DSHEA).

Our IP Pledge

We do not own consumer brands. We never compete with our clients.

Every formula engineered at Olympia Biosciences™ is built from scratch and transferred to you with full intellectual property ownership. Zero conflict of interest — guaranteed by ISO 27001 cybersecurity and ironclad NDAs.

Explore IP Protection

Cite

APA

Baranowska, O. (2026). Quantum Theories of Consciousness in Psychiatry: The Orchestrated Objective Reduction (Orch-OR) Hypothesis. Olympia R&D Bulletin. https://olympiabiosciences.com/rd-hub/quantum-consciousness-psychiatry-orch-or/

Vancouver

Baranowska O. Quantum Theories of Consciousness in Psychiatry: The Orchestrated Objective Reduction (Orch-OR) Hypothesis. Olympia R&D Bulletin. 2026. Available from: https://olympiabiosciences.com/rd-hub/quantum-consciousness-psychiatry-orch-or/

BibTeX
@article{Baranowska2026quantumc,
  author  = {Baranowska, Olimpia},
  title   = {Quantum Theories of Consciousness in Psychiatry: The Orchestrated Objective Reduction (Orch-OR) Hypothesis},
  journal = {Olympia R\&D Bulletin},
  year    = {2026},
  url     = {https://olympiabiosciences.com/rd-hub/quantum-consciousness-psychiatry-orch-or/}
}

Executive protocol review

Article

Quantum Theories of Consciousness in Psychiatry: The Orchestrated Objective Reduction (Orch-OR) Hypothesis

https://olympiabiosciences.com/rd-hub/quantum-consciousness-psychiatry-orch-or/

1

Send Olimpia a note first

Let Olimpia know which article you'd like to discuss before booking your slot.

2

OPEN EXECUTIVE ALLOCATION CALENDAR

Select a qualification slot after submitting mandate context to prioritize strategic fit.

OPEN EXECUTIVE ALLOCATION CALENDAR

Express Interest in This Technology

We'll follow up with licensing or partnership details.

Article

Quantum Theories of Consciousness in Psychiatry: The Orchestrated Objective Reduction (Orch-OR) Hypothesis

No spam. Olimpia will review your signal personally.